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Summary 
Objectives: Thrombospondins, which are known to interact with the α2δ subunit of voltage-sensitive 
calcium channels to stimulate the formation of excitatory synapses, have recently been implicated in 
the process of epileptogenesis. No studies have been so far performed on thrombospondins in models 
of absence epilepsy. We examined whether expression of the gene encoding for thrombospondin-1 
was altered in the brain of WAG/Rij rats, which model absence epilepsy in humans. In addition, we 
examined the frequency of genetic variants of THBS1 in a large cohort of children affected by 
idiopathic/genetic generalized epilepsies (IGE/GGEs). 
Methods: We measured the transcripts of thrombospondin-1 and α2δsubunit, and protein levels of 
α2δ, Rab3A, and the vesicular glutamate transporter, VGLUT1, in the somatosensory cortex and 
ventrobasal thalamus of pre-symptomatic and symptomatic WAG/Rij rats and in two control strains 
by real-time PCR and immunoblotting. We examined the genetic variants of THBS1 and CACNA2D1 
in two independent cohorts of patients affected by IGE/GGE recruited through the Genetic 
Commission of the Italian League Against Epilepsy (LICE) and the EuroEPINOMICS-CoGIE 
Consortium. 
Results: Thrombospondin-1 mRNA levels were largely reduced in the ventrobasal thalamus of both 
pre-symptomatic and symptomatic WAG/Rij rats, whereas levels in the somatosensory cortex were 
unchanged. VGLUT1 protein levels were also reduced in the ventrobasal thalamus of WAG/Rij rats. 
Genetic variants of THBS1 were significantly more frequent in patients affected by IGE/GGE than in 
non-epileptic controls, whereas the frequency of CACNA2D1 was unchanged. 
Significance: These findings suggest that thrombospondin-1 may have a role in the pathogenesis of 
IGE/GGEs.  
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Key Points: 
1) Expression of thrombospondin-1 gene is reduced in the ventrobasal thalamus of a genetic rat model 
of absence epilepsy. 
2) This reduction precedes the onset of absence seizures, linking thrombospondin-1 to the 
pathogenesis of absence epilepsy.  
3) Genetic variants of THBS1 (the gene encoding for thrombospondin-1) are more frequent in patients 
with IGE/GGE than in healthy controls. 
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Introduction 
Absence epilepsy is a non-convulsive type of epilepsy characterized by brief periods of 
unresponsiveness associated with typical spike-and-wave discharges (SWDs) in the EEG. SWDs are 
generated within a cortico-thalamo-cortical network formed by highly excitable neurons in the 
subgranular layer of the facial region of the somatosensory cortex interconnected with neurons of the 
reticular and ventrobasal thalamic nuclei.1,2 T-type voltage-sensitive Ca2+ channels (VSCCs) are 
critically involved in the generation of SWDs, as demonstrated by the ability of the T-channel blocker, 
ethosuximide, to normalize the activity of highly excitable cortical neurons and to reduce burst firing 
of reticular and ventrobasal thalamic neurons.3,4  
A growing body of evidence suggests a potential role for the 2 subunit of VSCCs in the 
pathophysiology of non-convulsive epilepsy. The mutant mouse ducky, which carries a mutation for 
the gene encoding for the 2-2 subunit, is characterized by absence seizures and ataxia. In addition, 
gabapentin and pregabalin, which bind to, and negatively modulate 2-1 and 2-2 proteins, may 
precipitate absence seizures in experimental animal models and humans.5,6 The 2 subunit is known 
to regulate trafficking, current amplitude, and activation/inactivation kinetics of high-voltage 
activated VSCCs (e.g., L-, N-, and P/Q-type VSSCs).7 The role of 2 subunit in the regulation of T-
type channels is less clear. Formation of a multimolecular complex between the 1 subunit of T 
channels and auxiliary subunits (2, , and  subunits) has not been demonstrated, as yet. However, 
there is evidence that expression of the 2subunit increases plasma membrane localization and 
current density of T channels8-10 (see also Lacinová et al.,11 for contrasting data). These findings are 
difficult to reconcile with the evidence that genetic deletion or pharmacological blockade of the 2 
subunit causes absence seizures (see above), unless the function of the 2 subunit is not restricted to 
the modulation of VSCCs. Interestingly, 2-1 has been identified as a high affinity receptor for 
thrombospondins,12 which, in the CNS, are secreted from astrocytes and promote synaptic formation 
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under physiological and pathological conditions.13,14 The interaction between the epidermal growth 
factor-like domains of thrombospondins and 2-1 mediates the effect of thrombospondins on 
synaptic formation. Interestingly, the 2 ligand, gabapentin, inhibits the induction of excitatory 
synaptic formation by thrombospondins.12 This stimulates interest for the study of thrombospondins 
in models of absence epilepsy.  
We used WAG/Rij rats, which develop spontaneous generalized bilateral symmetrical SWDs 
associated with absence-like behavior after 2-3 months of age.15,16 SWDs in symptomatic WAG/Rij 
rats are reduced by classical anti-absence drugs, such as ethosuximide and valproate, and are increased 
by drugs that aggravate absence seizures in humans, such as phenytoin, carbamazepine, tiagabine, and 
vigabatrin.17-19 This makes WAG/Rij rats a valuable model for the study of human absence epilepsy. 
We now report that the transcript of thrombospondin-1 was largely reduced in the ventrobasal 
thalamus of WAG/Rij rats, both in the pre-symptomatic and symptomatic age, as compared to non-
epileptic controls. We then examined the variants of THBS1 and CACNA2D1 in a cohort of patients 
with idiopathic/genetic generalized epilepsy (IGE/GGE) and found that variants in THBS1 but not in 
CACNA2D1 were enriched in patients respect to control population. These findings support a potential 
role for thrombospondins in epileptogenesis and raise the interesting possibility that changes in the 
expression and/or biological function of thrombospondin-1 contributes to the pathogenesis of absence 
epilepsy. 
 
Methods 
Animals 
We used male WAG/Rij rats at 2 or 6 months of age raised at Radboud University, Nijmegen, The 
Netherland. WAG/Rij rats of 2 months of age do not show SWDs as yet, and, therefore, are considered 
“pre-symptomatic”. All 6-month-old WAG/Rij rats have about 16-20 SWDs per hour, or more than 
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200 SWDs per day,15 and are thus defined as “symptomatic”. As control rats, we used age-matched 
Agouti Copenhagen Irish (ACI) rats or age-matched Wistar rats. ACI rats show no or only very few 
SWDs and the lowest number of SWDs of all inbred strains investigated, as assessed in a 48 h EEG 
evaluation study,20 and in all cases they have much less SWDs than WAG/Rij rats of the same age.21 
However, ACI rats have a different genetic background with respect to WAG/Rij rats. Wistar rats 
have the same genetic background of WAG/Rij rats, and may occasionally develop SWDs or have no 
SWDs at all, depending on the substrain. 22,23 Rats were housed under a 12h-12h light/dark cycle under 
standard conditions, food, water and cage enrichment were always available. All efforts were done to 
cause as little discomfort as possible, and to use as few animals as was considered meaningful. Ethical 
approval was obtained from RU-DEC. For the analysis of Thbs1 and Cacna2d1 transcripts we 
performed two independent experiments. In a first experiment, we examined the two transcripts in the 
ventrobasal thalamus, somatosensory cortex, and motor cortex from WAG/Rij and age-matched ACI 
rats. In a second experiment, we measured the transcript of Thbs1 in the ventrobasal thalamus and 
somatosensory cortex in a new set of 6-month-old WAG/Rij and Wistar rats. For Western blot analysis 
of 21, Rab3A, and VGLUT1 protein levels, we compared WAG/Rij, ACI, and Wistar rats for 
measurements in the ventrobasal thalamus, and WAG/Rij and ACI rats for measurements in the 
somatosensory cortex. 
 
Biochemical analysis of the principal areas of the cortico-thalamo-cortical network 
Male WAG/Rij and age-matched control ACI or Wistar rats of 2 or 6 months of age were decapitated 
and brains were rapidly dissected out and frozen. The brains from each rat were coded and codes were 
released after biochemical analysis. Brains were cut coronally by a cryostat, and tissue that comprises 
the principal area of the cortico-thalamo-cortical network were dissected using the coronal diagrams 
(between coordinates from bregma - 1.88 mm and - 3.80 mm), according to Paxinos and Watson atlas 
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as a guide. For cortical areas, we dissected a part of the cortex that included the primary somatosensory 
cortex (S1) and another portion of the cortex that included the primary motor cortex (M1). A thalamic 
portion containing ventrobasal thalamic nuclei (VB) was also dissected. 
 
RNA isolation, reverse transcription and quantitative real-time PCR 
Total RNA was extracted from different brain regions of the cortico-thalamo-cortical network in 
Trizol reagent according to manufacturer's protocol. The RNA was further treated with DNase 
(Qiagen, Hilden, Germany) and single strand cDNA was synthesized from 2 μg of total RNA using 
superscript III (Invitrogen, Carlsbad, CA, USA) and random hexamers. Real-time PCR was performed 
on 20 ng of cDNA by using specific primers and Power SYBR Green Master Mix (Applied Biosystem, 
Foster City, CA, USA) on an Applied Biosystems Step-One instrument. Thermal cycler conditions 
were as follows: 10 min at 95°C, 40 cycles of denaturation (15 sec at 95°C), and combined 
annealing/extension (1 min at 60°C). Primers used were as follows: Thbs1 Forw 
TCGGGGCAGGAAGACTATGA and Rev ACTGGGCAGGGTTGTAATGG; Cacna2d1 Forw 
CAGCAATGCTCAGGATGTGA and Rev ATCTGTTATCCCCTTTGCT; and -actin Forw 
GTTGACATCCGTAAAGACC and Rev TGGAAGGTGGACAGTGAG. mRNA copy number of 
each gene analyzed was calculated from serially diluted standard curves simultaneously amplified 
with the samples and normalized against -actin copy number. Statistical analysis was performed by 
two-way ANOVA + Fisher test. 
 
Western blot analysis 
Western blot analysis was carried out in the ventrobasal thalamus and in the somatosensory cortex 
dissected from WAG/Rij and age-matched control ACI or Wistar rats, at 2 or 6 months of age (n = 6 
rats per group). Tissue samples were homogenized at 4°C in 50 mM Tris-HCl buffer, pH 7.4, 
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containing 1mM EDTA, 1% Triton X-100, 1 mM PMSF, 1 g/ml aprotinin, 1 g/ml pepstatin, and 1 
g/ml leupeptin. Proteins were resuspended in SDS-bromophenol blue reducing buffer with 40 M 
DTT. Western blot analyses were carried out using 8, 10 or 12% SDS polyacrylamide gels, which 
were electroblotted onto immunoblot PVDF membranes (BioRad, Milano, Italy); filters were blocked 
overnight in TTBS buffer containing 5% BSA or 5% non-fatty milk. Specific rabbit polyclonal 
antibodies for Rab3A (1:1000, Cell Signaling Technology, Danvers, MA, USA), VGLUT1 (1:1000, 
Cell Signaling Technology), α2δ-1 (1:200, Sigma, St. Louis, MO) or mouse monoclonal antibody for 
-actin (1:100.000, Sigma) were used. We also used four commercially available anti-
thrombospondin-1 antibodies (1:300, Calbiochem, S. Diego, CA; 1:500, Abcam, Cambridge, MA; 
1:500, Thermo Scientific, Rockford, IL; 1:1000, R&D Systems, Minneapolis, MN). Blots were then 
incubated for 1 h with secondary antibodies (peroxidase-coupled anti-rabbit or anti-mouse, 
Amersham, Piscataway, NJ) diluted 1:7000 with TTBS. Immunostaining was revealed by enhanced 
ECL (Amersham). 
 
Patients, sequencing, and annotation of the variants 
Whole-exome sequencing data from two independent cohorts of IGE/GGE patients recruited through 
the Genetic Commission of the Italian League Against Epilepsy (LICE) and the EuroEPINOMICS-
CoGIE Consortium (Appendix 1), were analyzed. Their clinical information, including data on EEG 
and antiepileptic therapy, were recorded on data collection forms. Available charts and investigations 
were reviewed by experienced neurologists (PS, HL, PP) before making a final clinical diagnosis. 
Genomic DNA isolation and genetic analysis was carried out with the Nimblegen-SeqCapEZ-V244M 
enrichment kit on the Illumina HiSeq2000 system as described.24,25 Only samples with a minimum of 
90% of all bases in the coding region of the THBS1 and CACNA2D1 being covered by at least 11 
reads were used and the HGMD variants identified in the patients were validated by Sanger 
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sequencing. Variant annotation was performed using the HGMD Professional 2013. Variant 
frequencies (minor allele frequency, MAF, >1%) were obtained from the ExAC collection 
(http://exac.broadinstitute.org/). Statistical analysis was carried out by means of two-tailed chi-square 
with Yates correction. 
 
Results 
Reduced thrombospondin-1 gene expression in the ventrobasal thalamus in spontaneously epileptic 
WAG/Rij rats  
We used WAG/Rij rats at 2 and 6 months of age (corresponding to a pre-symptomatic and 
symptomatic age, respectively) and age-matched control ACI or Wistar rats for the analysis of 
thrombospondin-1, 2-1 subunit, and two biochemical markers of glutamatergic terminals, i.e., 
Rab3A and VGLUT1. All symptomatic WAG/Rij rats show a high frequency of SWDs recorded by 
EEG as exemplified in Fig. 1. Thbs1 mRNA levels were largely reduced in the ventrobasal thalamus 
of both pre-symptomatic and symptomatic WAG/Rij rats, as compared to age-matched non-epileptic 
control rats (Fig. 2A). Levels did not differ between pre-symptomatic and symptomatic WAG/Rij rats 
(Fig. 2A), suggesting that the reduced expression of thrombospondin-1 in the ventrobasal thalamus is 
not an epiphenomenon of SWDs in WAG/Rij rats. No changes in thrombospondin-1 mRNA levels 
were found in the somatosensory and motor cortex of WAG/Rij rats at both 2 and 6 months of age 
(Fig. 2A). To exclude that the observed difference in thalamic Thbs1 mRNA levels between WAG/Rij 
and ACI rats was due to the different genetic background of the two strains of rats, we performed an 
additional experiment in which the transcript of Thbs1 was measured in the ventrobasal thalamus of 
WAG/Rij rats and Wistar rats at 6 months of age. Levels were significantly lower in the ventrobasal 
thalamus of WAG/Rij rats, whereas no changes were found in the somatosensory cortex (Fig. 2B). 
We were unable to measure thrombospondin-1 protein levels in brain regions of WAG/Rij and control 
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rats because we could not detect a clean band, corresponding to the deduced molecular size of 
thrombospondin-1 by Western blot analysis, using four commercially available anti-thrombospondin-
1 antibodies. 
In contrast to thrombospondin-1, no changes in the transcript of Cacna2d1 were found in the 
ventrobasal thalamus, somatosensory, and motor cortex of WAG/Rij rats as compared to ACI rats 
(Fig. 2C). In the somatosensory cortex, the transcript of 2-1 showed a trend to a reduction with age 
in both WAG/Rij and ACI rats, whereas a significant increase with age was seen in the motor cortex 
(Fig. 2C). Immunoblot analysis showed no changes in 2-1 protein levels in the ventrobasal thalamus 
of WAG/Rij rats at 2 or 6 months of age, as compared to age-matched ACI or Wistar rats (Fig. 3A). 
Knowing that thrombospondins enhance the formation of glutamatergic synapses by interacting with 
2-1,12 we extended the analysis to Rab3A and VGLUT1, which are established presynaptic markers 
of glutamatergic terminals. Rab3A levels did not change in the ventrobasal thalamus of pre-
symptomatic and symptomatic WAG/Rij rats, as compared to ACI or Wistar rats (Fig. 3B). In contrast, 
there was a significant strain- and age-related reduction (but not strain x age difference) of VGLUT1 
in the ventrobasal thalamus of WAG/Rij rats as compared to ACI or Wistar rats (Fig. 3C). No changes 
in 2-1, Rab3A, or VGLUT1 protein levels were found in the somatosensory cortex of WAG/Rij rats 
as compared to age-matched ACI rats (Fig. 3D-F).  
 
Genetic variants in the THBS1 gene encoding for thrombospondin-1 are more frequent in 
IGE/GGE patients 
Overall, 238 patients affected by IGE/GGE were included in the analysis (Supplementary Table 1). 
One hundred and forty-three patients were affected by childhood absence epilepsy (CAE); 21 patients 
by juvenile absence epilepsy (JAE); 47 patients by juvenile myoclonic epilepsy (JME); and 27 patients 
by generalized tonic-clonic seizures alone (EGTC). All subjects were of European descent (Italian 
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128, German 54, Finnish 22, Dutch 11, British 9, Danish 8, Turkish 6). The cohort included 138 
female subjects (58%). Age of epilepsy onset ranged from 5 years to 38 years with a median of 8 
years. The majority of cases (n=183) derived from multiplex families with at least 2 affected family 
members. The large majority of the patients (n=189; 79.4%) were treated with one anti-seizure drug, 
usually valproate or levetiracetam. 
In this cohort, we identified a total of 11 variants (8 distinct HGMD missense mutations in THBS1 
and 3 in CACNA2D1) in the whole IGE/GGE cohort (total frequency = 4.62%). Details of the 
identified variants and their frequency are reported in Table 1. Variants in THBS1 were enriched in 
the IGE/GGE cohort (8/238; 3.36 %) compared with control population (1829/121230; 1.5%) 
(p=0.03). In contrast, variants in CACNA2D1 were not more frequent in patients (3/238; 1.26 %) than 
in control populations (733/120817;0.6%) (p = 0.37) (Table 2). Syndrome subdivision analysis failed 
to demonstrate that variants in both genes were specifically enriched in CAE syndrome 
(Supplementary Table 2). 
 
Discussion 
Thrombospondin-1, one of the five members of the thrombospondin family, is widely expressed in 
the organism and is known to regulate fundamental cell biological processes, such as cell attachment 
to extracellular matrix, cytoskeletal dynamics, and cell migration. In the developing CNS, astrocyte-
secreted thrombospondin-1 promotes synaptogenesis, neuronal migration, and axonal growth.13,26-29 
The demonstration that thrombospondin-1 interacts with the α2δ-1 subunit to stimulate the formation 
of excitatory synapses12 raised interest on the potential role of thrombospondin-1 in disorders that are 
targeted by α2δ ligands, such as neuropathic pain and epilepsy. Several lines of evidence suggest that 
an abnormal synaptogenesis contributes to epileptogenesis, i.e., to the process by which the brain 
develops epilepsy. Accordingly, temporal lobe epilepsy in patients and pilocarpine-induced epilepsy 
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in rats are associated with an increased hippocampal and cortical expression of ephrinB3 and its 
receptor EphB3, which play a key role in synaptogenesis and mechanisms of synaptic reorganization 
and plasticity.30 Other proteins that regulate synaptogenesis, such as synapsin II and synaptophysin, 
have been also implicated in the pathophysiology of epilepsy.31,32 Interestingly, matrix 
metalloproteinases (MMPs), which cleave extracellular matrix (EM) proteins and regulate 
synaptogenesis, have an active role in epileptogenesis in different experimental animal models,33 and 
the EM protein, SC1, translocates from neuronal cell bodies to excitatory nerve terminals following 
status epilepticus in the rat lithium-pilocarpine model.34 
Recent evidence suggests that thrombospondin-1, by promoting the formation of new excitatory 
synapses, contributes to the development of a hyperexcitable neuronal network, which is a critical 
event in epilepsy. Mendus et al.35 have found that mice lacking thrombospondin-1 or thrombospondins 
1 and 2 were more sensitive to pentylenetetrazole kindling. These mice also showed a reduced 
expression of α2δ-1/2 protein levels in the cortex, suggesting that the thrombospondin/α2δ axis is a 
key regulator of susceptibility to seizures.35 The importance of the thrombospondin/α2δ axis in the 
pathophysiology of epilepsy is supported by the evidence that mice overexpressing α2δ-1 show 
epileptiform activity and behavioral arrests associated with an increased number of excitatory 
synapses in the cortex.36 
Here, we showed for the first time that expression of the Thbs1 gene encoding for thrombospondin-1 
was substantially reduced in the ventrobasal thalamus of WAG/Rij rats, which represent an established 
genetic animal model of spontaneous absence epilepsy.15,16 Remarkably, a large reduction in Thbs1 
mRNA levels was observed both in pre-symptomatic and symptomatic WAG/Rij rats, suggesting that 
a reduced production of thrombospondin-1 in the thalamus was not secondary to the occurrence of 
SWDs in the cortico-thalamo-cortical network underlying absence seizures. As opposed to mice 
lacking thrombospondin-1,35 we did not detect changes in α2δ-1 mRNA and protein levels associated 
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with the reduction of thrombospondin-1 in WAG/Rij rats. In contrast, WAG/Rij rats showed lowered 
VGLUT1 levels in the thalamus with respect to non-epileptic control rats, suggesting that the reduced 
expression of Thbs1 gene might have caused an impaired formation of excitatory synapses in the 
thalamus of WAG/Rij rats.  
No changes in THBS-1 gene expression or VGLUT1 protein levels were found in the site of origin of 
the SWDs, the somatosensory cortex, suggesting that a possible defect in thalamic synaptogenesis 
combines with a cortical generator in the pathophysiology of absence seizures. The relevance of a 
defective synaptogenesis in the pathophysiology of absence seizures is supported by the evidence that 
stargazer mice, which show absence seizures, are characterized by an impairment of synaptic 
formation in the cerebellum,37 which exerts a modulatory role on generalized SWDs through the firing 
of deep cerebellar nuclei.38,39 Double mutant zi/zi tm/tm rats, which represent another rat model of 
spontaneous absence epilepsy, show a reduced expression of the synaptic vesicle proteins, SV2A and 
synaptotagmin-1.40 A thalamic defect of excitatory synapses may reinforce the hyperpolarizing milieu 
generated by GABA released from neurons of the reticular thalamus, thereby facilitating the recovery 
of T channels from inactivation in ventrobasal thalamic neurons, which ultimately results into 
pathological oscillations of the cortico-thalamo-cortical network.3 This hypothesis warrants further 
investigation. Nevertheless, the suggestion that a defect of excitatory neurotransmission is involved 
in the pathophysiology of absence seizures is supported by the evidence that two types of glutamate 
receptors, the mGlu1 and mGlu5 metabotropic glutamate receptors, are down-regulated in the 
ventrobasal thalamus of symptomatic WAG/Rij rats, and pharmacological activation of either mGlu1 
or mGlu5 receptors reduces the frequency of SWDs.41,42  
IGE/GGE is the most common type of inherited epilepsy and including at least 4 well-established 
epilepsy syndromes, namely, CAE, JAE, JME, and EGTC; all of them characterized by the presence 
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of SWDs/polyspikes.43 Despite its high heritability of 80%, the genetic background is still largely 
unknown.44  
To assess the potential impact of thrombospondin and the 2-1 subunit in the pathophysiology of 
absence epilepsy in humans, we checked a large cohort of patients affected by IGE/GGE. This analysis 
revealed that genetic variants of THBS1 were significantly more frequent in patients affected by 
IGE/GGE than in non-epileptic controls, whereas the frequency of CACNA2D1 was unchanged. 
Syndromic stratification analysis failed to show that variants in both genes were specifically enriched 
in any of the IGE/GGE syndromes, including CAE, which is in line with the view that IGE/GGE is a 
spectrum of epilepsy syndromes with variable age at onset associated with common EEG traits 
generated by pathological oscillations in a cortico-thalamo-cortical network with a cortical origin.3 
In conclusion, we showed that expression of thrombospondin-1 gene is reduced in the ventrobasal 
thalamus of WAG/Rij rats, which model absence epilepsy in humans. This reduction precedes the 
onset of absence seizures, linking thrombospondin-1 to the pathogenesis of absence epilepsy in 
WAG/Rij rats. Moreover, a potential role for thromospondin-1 in the pathogenesis of generalized 
epilepsy is supported by the finding that polymorphic variants of the THBS1 gene showed a much 
higher frequency in a large cohort of patients affected by IGE/GGE compared to control population, 
although the increase was not significant in the sub-cohort of patients affected by CAE. Overall these 
findings support the hypothesis that the thrombospondin-1/α2δ-1 axis is involved in the 
pathophysiology of epilepsy and encourage further studies on the potential relationship between 
thrombospondin-1-regulated synaptic formation and epileptogenesis within the cortico-thalamo-
cortical network.  
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Helsinki, Finland; Neuroscience Center, University of Helsinki, Helsinki, Finland; Ann-Kathrin 
Ruppert, Cologne Center for Genomics, University of Cologne, Cologne, Germany; Auli Siren, 
Outpatient Clinic for Persons with Intellectual Disablity, Tampere University Hospital, Tampere, 
Finland; Bobby Koeleman, Department of Medical Genetics, Division of Biomedical Genetics, 
University Medical Center Utrecht, Utrecht, Netherlands; Dennis Lal, Cologne Center for Genomics, 
University of Cologne, Cologne, Germany; Felicitas Becker, Department of Neurology and 
Epileptology, Hertie Institute for Clinical Brain Research, University of Tubingen, Tubingen, 
Germany; Hande Caglayan, Department of Molecular Biology and Genetics, Bogazici University, 
Istanbul, Turkey; Helle Hjalgrim, Danish Epilepsy Centre, Dianalund, Denmark Institute for Regional 
Health Services, University of Southern Denmark, Odense, Denmark; Hiltrud Muhle, University 
Medical Center Schleswig- Holstein, Christian-Albrechts University, Kiel, Germany; Holger Thiele, 
Cologne Center for Genomics, University of Cologne, Cologne, Germany; Ingo Helbig, University 
Medical Center Schleswig- Holstein, Christian-Albrechts University, Kiel, Germany; Janine 
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(CECAD), University of Cologne, Cologne, Germany; Rikke Møller, Danish Epilepsy Centre, 
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Figure legends 
Fig. 1 – EEG recording showing a typical SWD in symptomatic 6-month-old WAG/Rij rats. 
 
Fig. 2 – Reduced Thbs1 transcript in the ventrobasal thalamus of WAG/Rij rats. 
mRNA levels of Thbs1 in the ventrobasal thalamus, somatosensory cortex, and motor cortex of 
WAG/Rij and ACI rats at 2 and 6 months of age are shown in (A). mRNA levels of Thbs1 in the 
ventrobasal thalamus and somatosensory cortex of 6-month-old WAG/Rij rats and age-matched 
Wistar rats are shown in (B). mRNA levels of Cacna2d1 in the ventrobasal thalamus, somatosensory 
cortex, and motor cortex of WAG/Rij and ACI rats at 2 and 6 months of age are shown in (C). In (A) 
and (C), and (B), values are means + S.E.M. of 4-5, and 6 animals per group, respectively. In (A), a 
strain effect for the thalamus was found (Two-way ANOVA: F(1,15) = 45.65, WAG/Rij < ACI); post-
hoc test (Fisher’s LSD) confirmed that this strain effect was present for both 2 and 6 months groups 
* p < 0.05. In (B), (Student’s t test, t10 = 6.81, *p < 0.05) strain difference in thalamus: 6-month-old 
WAG/Rij < age-mached Wistar rats. In (C), age effect in motor cortex *p<0.05 (Two-way ANOVA, 
F(1,13) = 6.56, older < younger rats); post-hoc test (Fisher’s LSD) confirmed that this age effect was 
present in both strains *p < 0.05.  
 
Fig. 3 – Reduced VGLUT1 protein levels in the ventrobasal thalamus of WAG/Rij rats. 
Western blot analysis of α2δ-1, Rab3A, and VGLUT1 in the ventrobasal thalamus of pre-symptomatic 
and symptomatic WAG/Rij rats and age-matched ACI or Wistar rats are shown in (A), (B), and (C), 
respectively. Representative immunoblots from 3 rats per group are shown. Densitometric values are 
means + S.E.M. of 6 rats per group. In (C), two-way ANOVA shows a significant strain effect (F(2,30) 
Santolini #24 
= 7.15; p<0.05) and age effect (F(1,30) = 4.18; p<0.05), but no strain x age interaction effect (F(2,30) = 
0.27; n.s.). p < 0.05 vs. 2-month-old ACI rats (*) or vs. 6-month-old ACI and Wistar rats (#). Western 
blot analysis of α2δ-1, Rab3A, and VGLUT1 in the somatosensory cortex of pre-symptomatic and 
symptomatic WAG/Rij rats and age-matched ACI rats are shown in (D), (E), and (F), respectively 
(densitometric values are means + S.E.M. of 6 rats per group). 
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Table 1. Summary of THBS1 and CACNA2D1 variants identified in the IGE/GGE cohort and their frequency from the ExAC 
collection (http://exac.broadinstitute.org/). 
Gene Genomic Position Protein change MAF* 
N° Minor Allele/ N° 
Total Alleles 
MAF* in 
Europeans 
N° Minor Allele/                
N° Total Alleles in 
Europeans 
THBS1 15:39874505 G/A p.R60H 0,00004949 6/121230 0,0000152 1/66600 
THBS1 15:39874642 G/T p.A106S NA NA NA NA 
THBS1 15:39874742 A/G p.H139R 0,0001324 16/120830 0,0001355 9/66438 
THBS1 15:39874918 C/T p.R198C 0,00003462 4/115536 0,0000313 2/63914 
THBS1 15:39883456 G/A p.R773H 0,0001483 18/121366 0 0/66698 
THBS1 15:39883721 G/A p.R810Q 0,00002472 3/121378 0,00002998 2/66712 
THBS1 15:39884907 G/A p.G891R NA NA NA NA 
THBS1 15:39886304 G/A p.R1091H 0,0001925 21/109102 0,0002008 12/59768 
CACNA2D1 7:81588616 T/G p.D1045A 0,002805 339/120840 0,004544 302/66464 
CACNA2D1 7:81599241 C/G p.S755T 0,0007741 93/120134 0,001209 80/66170 
CACNA2D1 7:81601108 C/T p.S709N 0,00269 324/120468 0,004103 272/66300 
* MAF = Minor Allele Frequency 
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Table 2. Statistical analysis of THBS1 and CACNA2D1 variants observed in patients affected 
by IGE/GGE and in subjects from the ExAC collection (http://exac.broadinstitute.org/).   
__________________________________________________________________ 
THBS1            Patients       ExAC collection      Total 
Mutated    8           1829   1837 
Wild-type    230  121183  121413 
Total     238  121230  123250 
% of mutated   3.36  1.5   *p=0.03 
 
CACNA2D1            Patients       ExAC collection      Total 
Mutated    3           733   736 
Wild-type    235  120084  120319 
Total     238  120817  121055 
% of mutated   1.26  0.6   *p=0.37 
----------------------------------------------------------------------------------------------------- 
*two-tailed chi-square with Yates correction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Santolini #27 
Supplementary Table 1. Clinical data overview of the investigated IGE/GGE cohort. 
 
 
 
 
 
 
 
 
 
Gender 100 males, 138 females 
Age of Onset Mean 8.0  years (range: 5-38 years) 
Origin (n) 
Italian (128), German (54), Finnish (22), 
Dutch (11), British (9), Danish (8), 
Turkish (6) 
Epilepsy diagnosis (n) 
CAE (143), JAE (21), JME (47), EGTC 
(27)  
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Supplementary Table 2. Statistical analysis of THBS1 and CACNA2D1 variants observed in 
CAE patients and in controls from the ExAC collection (http://exac.broadinstitute.org/).   
__________________________________________________________________ 
THBS1            Patients       ExAC collection      Total 
Mutated    3               1829   1837 
Wild-type    140  121183  121413 
Total     143  121230  123250 
% of mutated    2.1  1.5   *p=0.79 
 
CACNA2D1            Patients       ExAC collection      Total 
Mutated    1                    733   736 
Wild-type    142  120084  120319 
Total     143  120817  121055 
% of mutated    0.7  0.6   *p=0.88 
----------------------------------------------------------------------------------------------------- 
*two-tailed chi-square with Yates correction. 
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